Genesis Healthcare, Inc. (GENN)
Total Valuation
GENN has a market cap or net worth of $602,462. The enterprise value is $3.46 billion.
| Market Cap | 602,462 |
| Enterprise Value | 3.46B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GENN has 167.35 million shares outstanding. The number of shares has decreased by -32.37% in one year.
| Shares Outstanding | 167.35M |
| Shares Change (YoY) | -32.37% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 33.68% |
| Owned by Institutions (%) | n/a |
| Float | 74.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.01 |
| PS Ratio | n/a |
| Forward PS | 0.00 |
| PB Ratio | n/a |
| P/FCF Ratio | 0.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.76, with a EV/FCF ratio of 65.49.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | 11.76 |
| EV / EBIT | 47.46 |
| EV / FCF | 65.49 |
Financial Position
| Current Ratio | 0.23 |
| Quick Ratio | 0.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | 12.96 |
| Debt / FCF | 72.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 44,000 |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.50% in the last 52 weeks. The beta is 0.12, so GENN's price volatility has been lower than the market average.
| Beta (1Y) | 0.12 |
| 52-Week Price Change | -98.50% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.13 |
| Average Volume (30 Days) | 35,655 |
Short Selling Information
The latest short interest is 2.30 million, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 2.30M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 3.08% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | 2.27B |
| Operating Income | -483.06M |
| Pretax Income | -62.57M |
| Net Income | -58.96M |
| Net Income Common | n/a |
| EBITDA | 294.02M |
| EBIT | 72.87M |
| Earnings Per Share (EPS) | -$0.53 |
Balance Sheet
The company has $352.75 million in cash and $3.81 billion in debt, giving a net cash position of -$3.46 billion or -$20.66 per share.
| Cash & Cash Equivalents | 352.75M |
| Total Debt | 3.81B |
| Net Cash | -3.46B |
| Net Cash Per Share | -$20.66 |
| Book Value | -820.22M |
| Book Value Per Share | -4.90 |
| Working Capital | -2.98B |
Cash Flow
In the last 12 months, operating cash flow was $315.73 million and capital expenditures -$262.93 million, giving a free cash flow of $52.80 million.
| Operating Cash Flow | 315.73M |
| Capital Expenditures | -262.93M |
| Free Cash Flow | 52.80M |
| FCF Per Share | $0.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GENN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 8,764.37% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 32.34% |
| Shareholder Yield | 32.34% |
Analyst Forecast
The average price target for GENN is $0.44, which is 12,122.22% higher than the current price. The consensus rating is "Sell".
| Price Target | $0.44 |
| Price Target Difference | 12,122.22% |
| Analyst Consensus | Sell |
| Analyst Count | 6 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |